Kagami Satoru, Funahashi Kimihiko, Kobayashi Hirotoshi, Kotake Kenjiro, Kawasaki Masayasu, Kinugasa Yusuke, Ueno Hideki, Maeda Kotaro, Suto Takeshi, Itabashi Michio, Ozawa Heita, Koyama Fumikazu, Noura Shingo, Ishida Hideyuki, Ohue Masayuki, Kiyomatsu Tomomichi, Ishihara Soichiro, Koda Keiji, Baba Hideo, Kawada Kenji, Hashiguchi Yojiro, Goi Takanori, Toiyama Yuji, Tomita Naohiro, Sunami Eiji, Fujita Fumihiko, Watanabe Jun, Hakamada Kenichi, Nakayama Goro, Sugihara Kenichi, Ajioka Yoichi
Department of General and Gastroenterological Surgery, Toho University Omori Medical Center, Tokyo, Japan.
Department of Surgery, Tokyo Metropolitan Hiroo Hospital, Tokyo, Japan.
J Anus Rectum Colon. 2025 Jan 25;9(1):134-144. doi: 10.23922/jarc.2024-056. eCollection 2025.
To clarify the risk factors affecting prognosis after primary tumor resection (PTR) in patients with metastatic colorectal cancer with synchronous peritoneal metastasis (mCRC-SPM).
Patients were enrolled prospectively in the JSCCR project "Grading of Peritoneal Seeding in Colorectal Cancer." Factors that may influence overall survival-age, sex, location of the primary tumor, lymph node metastasis, presence of liver metastasis, degree of peritoneal metastasis, peritoneal cancer index (PCI), cancer cure, and postoperative chemotherapy-in the PTR group were examined using multivariate analysis.
Of the 133 enrolled patients with mCRC-SPM, 112 patients underwent PTR. Among them, 26 (23.2%) had mCRC-SPM of grade P1, 47 (42.0%) of P2, and 39 (34.8%) of P3. The median PCI was 4 (range, 1-28); no surgery-related deaths occurred. Postoperative complications of Clavien-Dindo classification ≥grade 2 were observed in 20 (17.9%) patients. R0 surgery became more difficult as the degree of dissemination increased, and the PTR group had a significantly better prognosis than the non-PTR group. In the multivariate analysis, age ≥75 years, rectal cancer, presence of liver metastasis, higher PCI, non-curative resection, and non-treatment with systemic chemotherapy were associated with poor prognosis in patients after PTR.
In patients with mCRC-SPM, postoperative complications are infrequent for P1 with localized peritoneal dissemination, and PTR may be considered as aggressive treatment. Factors including age ≥75 years, rectal cancer, presence of liver metastasis, increased PCI, non-curative resection, and non-treatment with systemic chemotherapy are associated with a reduced survival benefit from PTR.
明确影响伴有同步腹膜转移的转移性结直肠癌(mCRC-SPM)患者原发肿瘤切除(PTR)后预后的危险因素。
前瞻性纳入日本结直肠癌学会项目“结直肠癌腹膜种植的分级”中的患者。使用多因素分析研究PTR组中可能影响总生存的因素,包括年龄、性别、原发肿瘤部位、淋巴结转移、肝转移情况、腹膜转移程度、腹膜癌指数(PCI)、癌症根治情况及术后化疗。
在133例纳入研究的mCRC-SPM患者中,112例接受了PTR。其中,26例(23.2%)为P1级mCRC-SPM,47例(42.0%)为P2级,39例(34.8%)为P3级。PCI中位数为4(范围1-28);未发生手术相关死亡。20例(17.9%)患者出现Clavien-Dindo分类≥2级的术后并发症。随着播散程度增加,R0手术难度增大,PTR组的预后明显优于非PTR组。多因素分析显示,年龄≥75岁、直肠癌、存在肝转移、PCI较高、非根治性切除以及未接受全身化疗与PTR术后患者的预后不良相关。
对于伴有局限性腹膜播散的P1级mCRC-SPM患者,术后并发症较少,PTR可被视为积极的治疗方法。年龄≥75岁、直肠癌、存在肝转移、PCI升高、非根治性切除以及未接受全身化疗等因素与PTR的生存获益降低相关。